GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Gross Block History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Gross Block | ₹716 Cr | ₹667 Cr | ₹663 Cr | ₹634 Cr | ₹592 Cr |
What is the latest Gross Block ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Gross Block |
|---|---|
| Mar2026 | ₹716 Cr |
| Mar2025 | ₹667 Cr |
| Mar2024 | ₹663 Cr |
| Mar2023 | ₹634 Cr |
| Mar2022 | ₹592 Cr |
How is Gross Block of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Gross Block | % Change | |
|---|---|---|---|
| Mar2026 | ₹716 Cr | 7.42 | |
| Mar2025 | ₹667 Cr | 0.52 | |
| Mar2024 | ₹663 Cr | 4.67 | |
| Mar2023 | ₹634 Cr | 7.11 | |
| Mar2022 | ₹592 Cr | - | |
Compare Gross Block of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹42,106.9 Cr | 1.7% | 17% | -24.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹468,458.0 Cr | 0.7% | 8.1% | 16% | Stock Analytics | |
| DIVIS LABORATORIES | ₹193,383.0 Cr | 7% | 10.2% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,829.0 Cr | 2.5% | 11.3% | 49.6% | Stock Analytics | |
| CIPLA | ₹116,164.0 Cr | -0.3% | 4.1% | -3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,648.0 Cr | -3.2% | -3.9% | -3% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 1.7% |
17% |
-24.4% |
| SENSEX | 0.9% |
2.2% |
-7.5% |
You may also like the below Video Courses